They provide the energy needed for all cells to function properly
Based on current trial populations and how the FDA has handled semaglutide and tirzepatide approvals, expected eligibility criteria are: BMI 30 , or BMI 27 with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, OSA) Adults 18 and older Not pregnant or breastfeeding No history of MTC or MEN 2 Retatrutide will almost certainly launch at a high price point estimates suggest $1,200$1,500 per month at list price
See the next Q/A below for more on state insurance requirements related to GLP-1 drugs
With your consent, we use the following third-party services on this website: Google Tag Manager, UET (Universal Event Tracking) Microsoft Consent Mode, Google Consent Mode, Klarna, Freshchat By accepting these services, we are able to show you videos or other media content hosted by external providers